Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 7—July 2007


Antimicrobial Drugs and Community-acquired Methicillin-Resistant Staphylococcus aureus, United Kingdom

Verena Schneider-Lindner*†, J. A. Delaney*†, Sandra Dial†‡, Andre Dascal‡, and Samy Suissa*†Comments to Author 
Author affiliations: *McGill University Health Center, Montreal, Quebec, Canada; †Royal Victoria Hospital, Montreal, Quebec, Canada; ‡Sir Mortimer B. Davis–Jewish General Hospital, Montreal, Quebec, Canada;

Main Article

Table 1

Characteristics of patients with (case-patients) and without (control-patients) a diagnosis of community-acquired methicillin-resistant Staphylococcus aureus*

Lifestyle factors
Smoking 718 (36.2) 6,365 32.2) 1.21 1.06 0.95–1.17
Obesity 323 (16.3) 2,253 (11.4) 1.54 1.27 1.10–1.47‡

*Data from the General Practice Research Database, United Kingdom, 2000–2004. OR, odds ratio; CI, confidence interval; MI, myocardial infarction; COPD, chronic obstructive pulmonary disease.
†Adjusted for all other variables in the table and exposure to antimicrobial drugs in the 30–365 days period before the index date.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO